Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 9Genitourinary 5Thoracic 3Plasma cell 3Head & Neck 3Gastrointestinal 3Lymphoid 2Tumor-Agnostic 1Other neoplasm 1Other hematologic neoplasm 1Other 1Gynecologic 1Dermatologic 1

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3cyclopia sequence 1Small Cell Lung Carcinoma 1Precancerous Conditions 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 551Pemetrexed 404Cisplatin 401Paclitaxel 273Docetaxel 255Gemcitabine 218pembrolizumab 191Bevacizumab 190Erlotinib Hydrochloride 184Radiotherapy 181Etoposide 147durvalumab 140Nivolumab 134Drug Therapy 127osimertinib 107atezolizumab 92Gefitinib 74Radiosurgery 72anlotinib 69Vinorelbine 68tislelizumab 52Irinotecan 51Ipilimumab 50130-nm albumin-bound paclitaxel 50Taxes 48Surgical Procedures, Operative 46Cetuximab 46sintilimab 45Albumin-Bound Paclitaxel 45apatinib 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Sugars × Thoracic × Clear all
NCT01636934 2020-07-17

Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy

M.D. Anderson Cancer Center

Phase 2 Completed
51 enrolled 8 charts
Thoracic

cyclopia sequence, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02285855 2020-01-06

Metformin in Non Small Cell Lung Cancer (NSCLC)

M.D. Anderson Cancer Center

Phase 2 Terminated
27 enrolled 11 charts
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00522197 2012-03-09

ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia

British Columbia Cancer Agency

Phase 2 Completed
90 enrolled
Other neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Precancerous Conditions, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡